vs

Side-by-side financial comparison of AVIENT CORP (AVNT) and Everus Construction Group, Inc. (ECG). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $760.6M, roughly 1.3× AVIENT CORP). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 2.2%, a 3.2% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs 1.9%). AVIENT CORP produced more free cash flow last quarter ($125.4M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs -4.2%).

Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.

AVNT vs ECG — Head-to-Head

Bigger by revenue
ECG
ECG
1.3× larger
ECG
$1.0B
$760.6M
AVNT
Growing faster (revenue YoY)
ECG
ECG
+31.3% gap
ECG
33.2%
1.9%
AVNT
Higher net margin
ECG
ECG
3.2% more per $
ECG
5.5%
2.2%
AVNT
More free cash flow
AVNT
AVNT
$101.9M more FCF
AVNT
$125.4M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
-4.2%
AVNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AVNT
AVNT
ECG
ECG
Revenue
$760.6M
$1.0B
Net Profit
$16.9M
$55.3M
Gross Margin
30.2%
11.6%
Operating Margin
5.2%
6.8%
Net Margin
2.2%
5.5%
Revenue YoY
1.9%
33.2%
Net Profit YoY
-65.0%
60.4%
EPS (diluted)
$0.18
$1.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVNT
AVNT
ECG
ECG
Q4 25
$760.6M
$1.0B
Q3 25
$806.5M
$986.8M
Q2 25
$866.5M
$921.5M
Q1 25
$826.6M
$826.6M
Q4 24
$746.5M
$759.6M
Q3 24
$815.2M
$761.0M
Q2 24
$849.7M
$703.4M
Q1 24
$829.0M
$625.7M
Net Profit
AVNT
AVNT
ECG
ECG
Q4 25
$16.9M
$55.3M
Q3 25
$32.6M
$57.0M
Q2 25
$52.6M
$52.8M
Q1 25
$-20.2M
$36.7M
Q4 24
$48.3M
$34.5M
Q3 24
$38.2M
$41.8M
Q2 24
$33.6M
$39.0M
Q1 24
$49.4M
$28.2M
Gross Margin
AVNT
AVNT
ECG
ECG
Q4 25
30.2%
11.6%
Q3 25
30.4%
12.6%
Q2 25
32.1%
13.0%
Q1 25
31.8%
11.2%
Q4 24
34.8%
11.4%
Q3 24
32.1%
11.8%
Q2 24
30.3%
12.6%
Q1 24
33.6%
11.9%
Operating Margin
AVNT
AVNT
ECG
ECG
Q4 25
5.2%
6.8%
Q3 25
8.3%
7.3%
Q2 25
11.1%
7.9%
Q1 25
0.1%
6.2%
Q4 24
11.5%
6.1%
Q3 24
9.5%
7.1%
Q2 24
8.5%
7.3%
Q1 24
11.3%
6.2%
Net Margin
AVNT
AVNT
ECG
ECG
Q4 25
2.2%
5.5%
Q3 25
4.0%
5.8%
Q2 25
6.1%
5.7%
Q1 25
-2.4%
4.4%
Q4 24
6.5%
4.5%
Q3 24
4.7%
5.5%
Q2 24
4.0%
5.5%
Q1 24
6.0%
4.5%
EPS (diluted)
AVNT
AVNT
ECG
ECG
Q4 25
$0.18
$1.09
Q3 25
$0.36
$1.11
Q2 25
$0.57
$1.03
Q1 25
$-0.22
$0.72
Q4 24
$0.53
$0.68
Q3 24
$0.41
$0.82
Q2 24
$0.36
$0.76
Q1 24
$0.54
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVNT
AVNT
ECG
ECG
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$1.9B
$281.5M
Stockholders' EquityBook value
$2.4B
$629.8M
Total Assets
$6.0B
$1.7B
Debt / EquityLower = less leverage
0.81×
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVNT
AVNT
ECG
ECG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$553.0K
Q2 24
Q1 24
Total Debt
AVNT
AVNT
ECG
ECG
Q4 25
$1.9B
$281.5M
Q3 25
$2.0B
$285.1M
Q2 25
$2.0B
$288.6M
Q1 25
$2.1B
$292.1M
Q4 24
$2.1B
$295.6M
Q3 24
$2.1B
Q2 24
$2.1B
Q1 24
$2.1B
Stockholders' Equity
AVNT
AVNT
ECG
ECG
Q4 25
$2.4B
$629.8M
Q3 25
$2.4B
$573.0M
Q2 25
$2.4B
$514.4M
Q1 25
$2.3B
$460.2M
Q4 24
$2.3B
$422.6M
Q3 24
$2.4B
$453.3M
Q2 24
$2.3B
$490.0M
Q1 24
$2.3B
$464.3M
Total Assets
AVNT
AVNT
ECG
ECG
Q4 25
$6.0B
$1.7B
Q3 25
$6.1B
$1.6B
Q2 25
$6.1B
$1.5B
Q1 25
$5.8B
$1.4B
Q4 24
$5.8B
$1.3B
Q3 24
$6.0B
$1.3B
Q2 24
$5.9B
Q1 24
$5.9B
Debt / Equity
AVNT
AVNT
ECG
ECG
Q4 25
0.81×
0.45×
Q3 25
0.83×
0.50×
Q2 25
0.86×
0.56×
Q1 25
0.90×
0.63×
Q4 24
0.89×
0.70×
Q3 24
0.88×
Q2 24
0.90×
Q1 24
0.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVNT
AVNT
ECG
ECG
Operating Cash FlowLast quarter
$167.8M
$48.2M
Free Cash FlowOCF − Capex
$125.4M
$23.5M
FCF MarginFCF / Revenue
16.5%
2.3%
Capex IntensityCapex / Revenue
5.6%
2.4%
Cash ConversionOCF / Net Profit
9.93×
0.87×
TTM Free Cash FlowTrailing 4 quarters
$195.0M
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVNT
AVNT
ECG
ECG
Q4 25
$167.8M
$48.2M
Q3 25
$72.1M
$76.2M
Q2 25
$112.8M
$25.3M
Q1 25
$-51.1M
$7.1M
Q4 24
$122.6M
Q3 24
$71.1M
$78.9M
Q2 24
$105.9M
Q1 24
$-42.8M
$21.9M
Free Cash Flow
AVNT
AVNT
ECG
ECG
Q4 25
$125.4M
$23.5M
Q3 25
$47.4M
$65.7M
Q2 25
$85.8M
$12.3M
Q1 25
$-63.6M
$-11.4M
Q4 24
$81.5M
Q3 24
$46.1M
$60.9M
Q2 24
$74.5M
Q1 24
$-67.2M
$12.6M
FCF Margin
AVNT
AVNT
ECG
ECG
Q4 25
16.5%
2.3%
Q3 25
5.9%
6.7%
Q2 25
9.9%
1.3%
Q1 25
-7.7%
-1.4%
Q4 24
10.9%
Q3 24
5.7%
8.0%
Q2 24
8.8%
Q1 24
-8.1%
2.0%
Capex Intensity
AVNT
AVNT
ECG
ECG
Q4 25
5.6%
2.4%
Q3 25
3.1%
1.1%
Q2 25
3.1%
1.4%
Q1 25
1.5%
2.2%
Q4 24
5.5%
Q3 24
3.1%
2.4%
Q2 24
3.7%
Q1 24
2.9%
1.5%
Cash Conversion
AVNT
AVNT
ECG
ECG
Q4 25
9.93×
0.87×
Q3 25
2.21×
1.34×
Q2 25
2.14×
0.48×
Q1 25
0.19×
Q4 24
2.54×
Q3 24
1.86×
1.89×
Q2 24
3.15×
Q1 24
-0.87×
0.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVNT
AVNT

Color Additives And Inks$466.0M61%
Specialty Engineered Materials$295.5M39%

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

Related Comparisons